Provided by Tiger Trade Technology Pte. Ltd.

crane

164.22
-3.3300-1.99%
Post-market: 164.220.00000.00%17:20 EDT
Volume:554.18K
Turnover:90.82M
Market Cap:9.46B
PE:26.28
High:165.83
Open:165.12
Low:162.55
Close:167.55
52wk High:214.31
52wk Low:127.04
Shares:57.60M
Float Shares:48.76M
Volume Ratio:1.02
T/O Rate:1.14%
Dividend:0.92
Dividend Rate:0.56%
EPS(TTM):6.25
EPS(LYR):6.26
ROE:17.91%
ROA:7.88%
PB:4.59
PE(LYR):26.25

Loading ...

Syndax Announces FDA Approval of Revuforj® (revumenib) in Adult and Pediatric Patients with Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia

GlobeNewswire
·
Oct 25, 2025

Can Crane's (CR) Recent Sales Slump Reshape Expectations for Margin Expansion?

Simply Wall St.
·
Oct 23, 2025

CERo Therapeutics Announces Third Dose for Patient in Phase 1 Clinical Trial of CER-1236 in AML

GlobeNewswire
·
Oct 21, 2025

Moody's Confirms ICBC Macau's "A2" Long-term Deposits Rating with a "Stable" Outlook

Deep News
·
Oct 21, 2025

Crane (CR): Assessing Valuation Following Declining Sales and Slower Organic Revenue Growth

Simply Wall St.
·
Oct 21, 2025

Why Is Genmab Stock Trading Lower On Monday?

Benzinga_recent_news
·
Oct 20, 2025

Antengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating Efficacy Across All CLDN18.2 Expression Levels and Exceptional Tolerability

prnewswire
·
Oct 20, 2025

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer

GlobeNewswire
·
Oct 18, 2025

Corbus Pharmaceuticals Presents CRB-701 Robust Clinical Responses in HNSCC and Cervical Cancers at ESMO25

GlobeNewswire
·
Oct 18, 2025

Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL

GlobeNewswire
·
Oct 17, 2025

Clean Energy Technologies, Inc. Advances Vermont Renewable Gas Project to Deliver Clean Power from Agricultural

GlobeNewswire
·
Oct 16, 2025

CERo Therapeutics Announces Completion of First Cohort of Phase 1 Clinical Trial of CER-1236 in AML

GlobeNewswire
·
Oct 13, 2025

Crane Company to announce third quarter 2025 results

Reuters
·
Oct 08, 2025

Crane Company Announces Date for Third Quarter 2025 Earnings Release and Teleconference

THOMSON REUTERS
·
Oct 08, 2025

Shutdown Hits Growth And Hurts American Workers, Bessent Says

Benzinga_recent_news
·
Oct 02, 2025

ZUSDURI™ Clinical Review Published in Reviews in Urology™ Highlights Durable Efficacy and Manageable Safety Profile in Recurrent Low-Grade, Intermediate-Risk Non–Muscle Invasive Bladder Cancer

GlobeNewswire
·
Oct 02, 2025

Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

GlobeNewswire
·
Oct 01, 2025

BRIEF-Crane Enters $900 Million Term Loan Agreement - SEC Filing

Reuters
·
Oct 01, 2025

Crane Co - Company Enters $900 Mln Term Loan Agreement - SEC Filing

THOMSON REUTERS
·
Oct 01, 2025

Crane Company Secures New $900 Million Credit Agreement with JPMorgan and Lenders to Fund Acquisition and Operations

Reuters
·
Oct 01, 2025